2×2×2析因随机临床试验STEPCARE中的交互作用及其对结论的潜在影响:一项模拟研究方案
该方案计划通过模拟含50个中心、3278例参与者的多中心试验,在对照组6个月全因死亡率假定为60%的条件下,考察STEPCARE试验中干预间不同水平交互作用对结局的影响。主要模拟结局为各场景下1类和2类错误风险,并量化在样本量增加5%时可接受的最大交互效应,以及为纳入小、中、大交互效应所需的样本量增量。
要点
- 模拟设置:50个中心、3278例参与者,对照组6个月全因死亡率假定为60%。
- 主要模拟结局为不同交互水平下1类和2类错误风险是否超过目标α和β水平。
- 在总体1类错误风险≤5%、2类错误风险≤10%时,量化样本量增加5%后可接受的最大交互效应。
核心结论
- 该模拟研究方案旨在为2×2×2析因随机临床试验的设计提供信息,说明所评估干预之间潜在交互作用可能如何影响结论。
研究设计与样本
- 模拟多中心试验,设50个中心、3278例参与者,对照组6个月全因死亡率假定为60%。
- 研究针对未来在院外心脏骤停后昏迷患者中开展的2×2×2析因随机临床STEPCARE试验(镇静、体温和血压干预)。
- 模拟考察干预间不同水平交互效应对结局的影响,主要模拟结局为各模拟场景下1类和2类错误风险。
主要发现
- 在保持总体1类错误风险≤5%、2类错误风险≤10%时,量化计划样本量增加5%以考虑试验干预间可能交互作用后可接受的最大交互效应。
- 评估交互效应如何影响可确认或拒绝的最小可检测差异,模拟中纳入5%(小)、10%(中)或15%(大)正向交互且无真实干预效应(1类错误),以及5%(小)、10%(中)或15%(大)负向交互且有真实干预效应(2类错误)。
- 进一步考察为考虑小、中或大交互效应所需增加的样本量。
关键数值与推荐
- 总体1类错误风险≤5%,2类错误风险≤10%。
- 计划样本量增加5%以考虑试验干预间可能交互作用。
- 正向交互效应水平:5%为小、10%为中、15%为大(模拟无真实干预效应,对应1类错误)。
- 负向交互效应水平:5%为小、10%为中、15%为大(模拟有真实干预效应,对应2类错误)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Randomised clinical trials with a factorial design may assess the effects of multiple interventions in the same population. Factorial trials are carried out under the assumption that the trial interventions have no interactions on outcomes. Here, we present a protocol for a simulation study investigating the consequences of different levels of interactions between the trial interventions on outcomes for the future 2×2×2 factorial designed randomised clinical Sedation, TEmperature, and Pressure after Cardiac Arrest and REsuscitation (STEPCARE) trial in comatose patients after out-of-hospital cardiac arrest. METHODS: By simulating a multisite trial with 50 sites and 3278 participants, and a presumed six-month all-cause mortality of 60% in the control population, we will investigate the validity of the trial results with different levels of interaction effects on the outcome. The primary simulation outcome of the study is the risks of type-1 and type-2 errors in the simulated scenarios, i.e. at what level of interaction is the desired alpha and beta level exceeded. When keeping the overall risk of type-1 errors ≤ 5% and the risk of type-2 errors ≤ 10%, we will quantify the maximum interaction effect we can accept if the planned sample size is increased by 5% to take into account possible interaction between the trial interventions. Secondly, we will assess how interaction effects influence the minimal detectable difference we may confirm or reject to take into account 5% (small interaction effect), 10% (moderate), or 15% (large) positive interactions in simulations with no 'true' intervention effect (type-1 errors) and small (5%), moderate (10%), or large negative interactions (15%) in simulations with 'true' intervention effects (type-2 errors). Moreover, we will investigate how much the sample size must be increased to account for a small, moderate, or large interaction effects. DISCUSSION: This protocol for a simulation study will inform the design of a 2×2×2 factorial randomised clinical trial of how potential interactions between the assessed interventions might affect conclusions. Protocolising this simulation study is important to ensure valid and unbiased results. TRIAL REGISTRATION: Not relevant.
引用
- Olsen MH, Jensen AKG, Dankiewicz J, et al. Interactions in the 2×2×2 factorial randomised clinical STEPCARE trial and the potential effects on conclusions: a protocol for a simulation study. Trials. 2022. PMID: 36273179. doi:10.1186/s13063-022-06796-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。